Private Advisor Group, LLC Glaukos Corp Transaction History

Private Advisor Group, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Oct 14, 2021	SELL	$47.43 - $84.23 $198,921 - $353,260	-4,194 Closed	0 $0
Q2 2021 Aug 12, 2021	SELL	$73.06 - $97.7 $32,877 - $43,965	-450 Reduced 9.69%	4,194 $356,000
Q1 2021 Apr 22, 2021	SELL	$70.43 - $97.42 $28,172 - $38,968	-400 Reduced 7.93%	4,644 $390,000
Q4 2020 Apr 01, 2021	BUY	$48.9 - $75.26 $246,651 - $379,611	5,044 New	5,044 $380,000
Q3 2020 Nov 02, 2020	SELL	$37.23 - $50.97 $103,350 - $141,492	-2,776 Closed	0 $0
Q2 2020 Aug 17, 2020	BUY	$28.78 - $46.83 $79,893 - $130,000	2,776 New	2,776 $107,000

342

47.1M

132K

188K

Ticker GKOS
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 47,596,900
Market Cap $6.79B
Description
Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

Stay updated on Private Advisor Group, LLC with notifications on news.